Lifitegrast (BioDeep_00000796648)
代谢物信息卡片
化学式: C29H24Cl2N2O7S (614.0681214)
中文名称: 立他司特
谱图信息:
最多检出来源 () 0%
分子结构信息
SMILES: CS(=O)(=O)C1=CC=CC(=C1)CC(C(=O)O)NC(=O)C2=C(C=C3CN(CCC3=C2Cl)C(=O)C4=CC5=C(C=C4)C=CO5)Cl
InChI: InChI=1S/C29H24Cl2N2O7S/c1-41(38,39)20-4-2-3-16(11-20)12-23(29(36)37)32-27(34)25-22(30)13-19-15-33(9-7-21(19)26(25)31)28(35)18-6-5-17-8-10-40-24(17)14-18/h2-6,8,10-11,13-14,23H,7,9,12,15H2,1H3,(H,32,34)(H,36,37)/t23-/m0/s1
描述信息
D019999 - Pharmaceutical Solutions > D009883 - Ophthalmic Solutions
C78283 - Agent Affecting Organs of Special Senses
S - Sensory organs > S01 - Ophthalmologicals
同义名列表
1 个代谢物同义名
数据库引用编号
6 个数据库交叉引用编号
- ChEBI: CHEBI:133023
- KEGGdrug: D10374
- PubChem: 11965427
- DrugBank: DB11611
- ChEMBL: CHEMBL2048028
- CAS: 1025967-78-5
分类词条
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
0 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:
- PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。
文献列表
- Christopher J Day, Benjamin Bailly, Patrice Guillon, Larissa Dirr, Freda E-C Jen, Belinda L Spillings, Johnson Mak, Mark von Itzstein, Thomas Haselhorst, Michael P Jennings. Multidisciplinary Approaches Identify Compounds that Bind to Human ACE2 or SARS-CoV-2 Spike Protein as Candidates to Block SARS-CoV-2-ACE2 Receptor Interactions.
mBio.
2021 03; 12(2):. doi:
10.1128/mbio.03681-20
. [PMID: 33785634] - Joseph Tauber. A 6-Week, Prospective, Randomized, Single-Masked Study of Lifitegrast Ophthalmic Solution 5\% Versus Thermal Pulsation Procedure for Treatment of Inflammatory Meibomian Gland Dysfunction.
Cornea.
2020 Apr; 39(4):403-407. doi:
10.1097/ico.0000000000002235
. [PMID: 31895884] - Jou-Ku Chung, Elizabeth Spencer, Matthew Hunt, Thomas McCauley, Devin Welty. Ocular Distribution and Pharmacokinetics of Lifitegrast in Pigmented Rabbits and Mass Balance in Beagle Dogs.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
2018 Jan; 34(1-2):224-232. doi:
10.1089/jop.2017.0106
. [PMID: 29267138] - Eric D Donnenfeld, Paul M Karpecki, Parag A Majmudar, Kelly K Nichols, Aparna Raychaudhuri, Monica Roy, Charles P Semba. Safety of Lifitegrast Ophthalmic Solution 5.0\% in Patients With Dry Eye Disease: A 1-Year, Multicenter, Randomized, Placebo-Controlled Study.
Cornea.
2016 Jun; 35(6):741-8. doi:
10.1097/ico.0000000000000803
. [PMID: 27055211] - Noelia A-González, Antonio Castrillo. Liver X receptors as regulators of macrophage inflammatory and metabolic pathways.
Biochimica et biophysica acta.
2011 Aug; 1812(8):982-94. doi:
10.1016/j.bbadis.2010.12.015
. [PMID: 21193033] - Charles P Semba, Dennis Swearingen, Valerie L Smith, Mary S Newman, Charles A O'Neill, John P Burnier, David B Haughey, Thomas R Gadek. Safety and pharmacokinetics of a novel lymphocyte function-associated antigen-1 antagonist ophthalmic solution (SAR 1118) in healthy adults.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
2011 Feb; 27(1):99-104. doi:
10.1089/jop.2009.0105
. [PMID: 20334535]